Jordenne/Barb and Jospeh
Member Since 2020
So I'm a new member just want to make sure I understand the general idea with TR.
Basically it's like playing chicken with driving the numbers as low as you can without getting lower than 2.7 so you start at a safe level and once you prove that's safe though data over a number of cycles you increase the dose and so on.
The idea is that as you get the BG levels lowers the difference between the peaks and the nadir will lower and jump start the Kitty's pancreas to heal and start producing insulin on its own.
Once this process begins you'll see the levels start to get lower without increasing the dose which will triggers dose reductions and with luck eventually youll earn a reduction to zero and thus start a OJT trial where we see if kitty will regulate on their own.
This is quite the difference from SLGS which if I understand correctly is just interested in getting a dose established that will keep the numbers low enough to prevent any clinical symptoms from developing but high enough to have a very low risk of hypo and a much reduced testing regime needed. The problem with doing this method is that it makes it much harder for the pancreas to jump start and start producing on its own
If I've made a mistake please let me know. It's difficult to wrap my head around it all and I want to make sure I've distilled the information properly
Basically it's like playing chicken with driving the numbers as low as you can without getting lower than 2.7 so you start at a safe level and once you prove that's safe though data over a number of cycles you increase the dose and so on.
The idea is that as you get the BG levels lowers the difference between the peaks and the nadir will lower and jump start the Kitty's pancreas to heal and start producing insulin on its own.
Once this process begins you'll see the levels start to get lower without increasing the dose which will triggers dose reductions and with luck eventually youll earn a reduction to zero and thus start a OJT trial where we see if kitty will regulate on their own.
This is quite the difference from SLGS which if I understand correctly is just interested in getting a dose established that will keep the numbers low enough to prevent any clinical symptoms from developing but high enough to have a very low risk of hypo and a much reduced testing regime needed. The problem with doing this method is that it makes it much harder for the pancreas to jump start and start producing on its own
If I've made a mistake please let me know. It's difficult to wrap my head around it all and I want to make sure I've distilled the information properly